New grants boost research into nutrition and the epigenome

News

Posted on

BC Children’s Hospital and University of British Columbia researchers, Dr. Michael Kobor and Dr. Yvonne Lamers, are leading two new international projects investigating the relationship between diet, the epigenome and health thanks to almost $900,000 in funding from the Canadian Institutes of Health Research (CIHR).

These projects – the only two awarded funding through CIHR’s Team Grant: Nutrition and the Epigenome competition in January, 2019 – will further research in the emerging field of epigenetics and contribute to the development of new approaches to improve care for nutrition-related diseases and better understand how to help kids in BC and beyond live long, healthy lives. Both projects were submitted as part of the Joint Program Initiative (JPI) Healthy Diet Healthy Lifestyle (HDHL) call for Biomarkers for Nutrition and Health.

In epigenetics, researchers investigate how an individual’s experiences, diet, environment and more, can influence whether genes are “turned on” or “turned off” – potentially impacting critical stages of development in early infancy and lifelong health.

Dr. Kobor received $445,400 over three years for his project “NutriPROGRAM.” Through this project, Dr. Kobor and researchers in Germany, Netherlands, Spain and the UK are working to discover how the diets of young children can change their metabolism and health later in life.

“If we can pinpoint how nutrition during infancy makes its mark on DNA, we can better assess a child’s potential health risks later in life,” says Dr. Kobor. “We are thrilled to have the opportunity to utilize these international collaborations in the pursuit of additional projects and research excellence here at BC Children’s Hospital Research Institute.”

Dr. Kobor is the lead of the Healthy Starts Research Theme, and an investigator at BC Children’s Hospital. He is also an investigator at the Centre for Molecular Medicine and Therapeutics, a professor in the UBC Department of Medical Genetics, Sunny Hill BC Leadership Chair in Child Development, and Tier 1 Canada Research Chair in Social Epigenetics.

Dr. Lamers is the international lead for the project – “EpiBrain: Epigenetic effects of B-vitamins on brain health throughout life: scientific substantiation and translation of evidence for health-improvement strategies.” CIHR contributed $450,000 of around $1 million internationally over three years. Together with colleagues in the UK and Spain, Dr. Lamers is investigating how B-vitamins in the first 1000 days of life can change the epigenetics related to cognitive development and brain function in childhood. Her project will also investigate how B-vitamin nutrition in later life impacts brain function, and how much this is related to epigenetic mechanisms, taking an across the lifecycle approach.

“Vitamins such as B12 and folate can influence the extent to which genes in our brains are turned on and by how much,” says Dr. Lamers. “We hope to understand this process better so we can advise parents and older generations on how best to eat for a healthier brain.”

Dr. Lamers is an investigator at BC Children’s Hospital, Tier 2 Canada Research Chair in Human Nutrition and Vitamin Metabolism, and Associate Professor in Human Nutrition at UBC.

Alan Worsley
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • Dads with kid in the pool
    News

    Research supports BC families in building healthy habits to prevent childhood obesity

    Unhealthy eating patterns, low physical activity, and a lot of sedentary or screen-related habits are linked to childhood obesity risk, which can lead to elevated blood pressure, sleep problems, orthopedic issues, and mental health challenges. Obesity-prevention resources that only focus on providing information often fall short because many families already know the basics. The biggest…

    Read more
  • News

    First-in-world BC patient successfully treated for rare immune disease

    A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”

    Read more
  • News

    Prescribing ice cream and countering misinformation: Q&A with Dr. Alastair McAlpine

    Born and raised in Johannesburg, Dr. Alastair McAlpine, a researcher with the Vaccine Evaluation Center (VEC) at BC Children’s Hospital Research Institute (BCCHR), is passionate about pediatric palliative care and infectious diseases. He received his medical training in South Africa, but limited vacancies to pursue a specialization in his desired field brought him to Vancouver. After meeting a…

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now